[Hiring] Safety Evidence Medical Lead @argenx

Role Description

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

To strengthen our Safety Evidence and Insights team, we are seeking an experienced pharmaceutical professional who can connect medical science, safety evidence, and business strategy across the product lifecycle. The Safety Evidence (Medical) Lead will generate and translate safety evidence into insights that differentiate argenx therapies, strengthen understanding of their benefit-risk profile, and inform evidence and product strategy.

This role combines medical/scientific expertise, data analytics, and strategic thinking, integrating evidence from internal safety data, real-world data, post-authorization studies, medical literature, and other relevant sources. The successful candidate will operate as both a strategic thought partner and hands-on evidence leader, bringing deep understanding of drug development, safety science, and the broader competitive environment.

We are looking for candidates based in Belgium, Switzerland, or US (EST time zone).

Qualifications

• Medical degree preferred; PhD, PharmD or comparable scientific qualification considered.
• Demonstrated expertise in immunology and/or patient safety.
• Strong medical/scientific background with pharmaceutical or biotechnology experience in strategic Medical Affairs, late-stage Clinical Development, Safety Evidence, Patient Safety or related evidence-generation roles.
• Minimum 5 years' experience leading scientific or clinical projects/studies.
• Working knowledge of GCP and GVP.

Requirements

• Identify opportunities for strategic differentiation by assessing the safety profiles of argenx products in the context of competitors and the evolving treatment landscape.
• Identify critical safety evidence gaps and translate them into evidence-generation priorities.
• Shape and contribute to Integrated Evidence Generation Plans (IEGPs), ensuring safety evidence supports meaningful scientific and strategic questions.
• Provide medical interpretation and contextualization of safety evidence across multiple data sources, converting complex data into decision-relevant insights.
• Provide safety expertise to cross-functional teams.
• Lead late-stage safety-focused studies, including real-world studies.
• Translate evidence into clear scientific narratives for internal and external stakeholders.

Benefits

• Inclusive environment with equal consideration for employment without discrimination.
• Opportunity to work in a dynamic and innovative biotech company.
• Engagement with a rich pipeline of differentiated assets.
• Collaboration with cross-functional teams and external experts.

Company Description

At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.

Before you submit your application, CV or any other personal details to us, please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates (“argenx”) will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights, please contact our Global Privacy Office by email at [email protected].